In Millions of USD
| 12 months ending 2013-12-31 |
Revenue | $2,500,000,000.00 |
Other Revenue, Total | $10,000,000.00 |
Total Revenue | $2,510,000,000.00 |
Cost of Revenue, Total | $2,025,000,000.00 |
Gross Profit | $476,900,000.00 |
Selling/General/Admin. Expenses, Total | $150,000,000.00 |
Research & Development | $136,990,000.00 |
Depreciation/Amortization | $- |
Interest Expense(Income) - Net Operating | $- |
Unusual Expense (Income) | $- |
Other Operating Expenses, Total | $- |
Total Operating Expense | $2,311,990,000.00 |
Operating Income | $198,010,000.00 |
Interest Income(Expense), Net Non-Operating | 0 |
Gain (Loss) on Sale of Assets | 0 |
Other, Net | $1,830,000.00 |
Income Before Tax | $199,840,000.00 |
Income After Tax | $139,888,000.00 |
Minority Interest | 0 |
Equity In Affiliates | 0 |
Net Income Before Extra. Items | $139,888,000.00 |
Accounting Change | 0 |
Discontinued Operations | 0 |
Extraordinary Item | 0 |
Net Income | $139,888,000.00 |
Preferred Dividends | 0 |
Income Available to Common Excl. Extra Items | $139,888,000.00 |
Income Available to Common Incl. Extra Items | $139,888,000.00 |
Basic Weighted Average Shares | 0 |
Basic EPS Excluding Extraordinary Items | 0 |
Basic EPS Including Extraordinary Items | 0 |
Dilution Adjustment | 0 |
Diluted Weighted Average Shares | 114,520,000.00 |
Diluted EPS Excluding Extraordinary Items | 1.221515892 |
Diluted EPS Including Extraordinary Items |
|
Dividends per Share - Common Stock Primary Issue | |
Gross Dividends - Common Stock |
|
Net Income after Stock Based Comp. Expense |
|
Basic EPS after Stock Based Comp. Expense |
|
Diluted EPS after Stock Based Comp. Expense |
|
Depreciation, Supplemental |
|
Total Special Items |
|
Normalized Income Before Taxes |
|
Effect of Special Items on Income Taxes |
|
Income Taxes Ex. Impact of Special Items |
|
Normalized Income After Taxes |
|
Normalized Income Avail to Common |
|
Basic Normalized EPS |
|
Diluted Normalized EPS | 1.221515892 |